Trends in immunoconjugate and ligand-receptor based targeting development for cancer therapy.

Abstract:

:Many agents used to treat cancer are toxic to normal tissues. Thus, treatments delivering drug specifically to tumour, while minimising exposure to normal tissue, may be advantageous over non-targeted treatments. The exquisite specificity of the immune system has been used successfully to help develop targeted anticancer agents. The most common (and successful) tissue-specific targeting strategies rely on antibody conjugates, but additional approaches, including targeting through cytokines, peptides and recombinant viruses, have also been used successfully. This review summarises the agents exploiting the immunological principles of target specificity to help maximise delivery to tumour while minimising collateral damage to normal tissues. Such targeted molecules are collectively referred to as immunoconjugates.

journal_name

Expert Opin Drug Deliv

authors

Brumlik MJ,Daniel BJ,Waehler R,Curiel DT,Giles FJ,Curiel TJ

doi

10.1517/17425247.5.1.87

subject

Has Abstract

pub_date

2008-01-01 00:00:00

pages

87-103

issue

1

eissn

1742-5247

issn

1744-7593

journal_volume

5

pub_type

杂志文章,评审
  • Development of next-generation macromolecular drugs based on the EPR effect: challenges and pitfalls.

    abstract:INTRODUCTION:A major problem with conventional antitumor therapeutics is nonselective delivery of cytotoxic drugs to normal vital organs and tissues but little delivery to tumor tissues. AREAS COVERED:Here, the authors describe the tumor selective delivery of antitumor drugs by taking advantage of nano-sized drugs and...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2014.955011

    authors: Nakamura H,Fang J,Maeda H

    更新日期:2015-01-01 00:00:00

  • Formulation strategies to modulate drug release from poloxamer based in situ gelling systems.

    abstract::Introduction: Poloxamer based in situ gelling systems offer numerous advantages in drug delivery; however, their application as prolonged-release delivery platforms is limited mainly due to their weak mechanical properties and the interconnected aqueous network causing fast gel erosion and drug diffusion.Area covered:...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2020.1731469

    authors: Abdeltawab H,Svirskis D,Sharma M

    更新日期:2020-04-01 00:00:00

  • An innovative corticosteroid/long-acting β2-agonist breath-triggered inhaler: facilitating lung delivery of fluticasone propionate/formoterol fumarate for the treatment of asthma.

    abstract::Introduction: Incorrect inhaler technique is one reason why the efficacies of inhaled asthma treatments in clinical trials and effectiveness in the real world differ. Inhaler technique is critical for drug delivery to the lungs; incorrect technique negatively impacts asthma control and long-term outcomes. Breath-trigg...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2019.1689957

    authors: Usmani O,Roche N,Marshall J,Danagher H,Price D

    更新日期:2019-12-01 00:00:00

  • Chitosan-based gastroretentive floating drug delivery technology: an updated review.

    abstract:INTRODUCTION:Gastroretentive floating drug delivery systems have emerged as efficient approaches for enhancing the bioavailability and controlled delivery of various therapeutic agents. Significant advancements exploiting chitosan have been made worldwide, in order to investigate these systems according to patient requ...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2012.673581

    authors: Pahwa R,Saini N,Kumar V,Kohli K

    更新日期:2012-05-01 00:00:00

  • Endothelial nanomedicine for the treatment of pulmonary disease.

    abstract:INTRODUCTION:Even though pulmonary diseases are among the leading causes of morbidity and mortality in the world, exceedingly few life-prolonging therapies have been developed for these maladies. Relief may finally come from nanomedicine and targeted drug delivery. AREAS COVERED:Here, we focus on four conditions for w...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2015.961418

    authors: Brenner JS,Greineder C,Shuvaev V,Muzykantov V

    更新日期:2015-02-01 00:00:00

  • Consequences of not-shaking and shake-fire delays on the emitted dose of some commercial solution and suspension pressurized metered dose inhalers.

    abstract:BACKGROUND:Pressurized metered-dose inhalers (pMDIs) include hydrofluoroalkane (HFA) propellant to generate a drug aerosol upon actuation and drugs can be formulated as solution or suspension. Suspended particles can cream or sediment depending on density differences between drug and propellant and shaking the pMDI is ...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章

    doi:10.1080/17425247.2020.1767066

    authors: Chierici V,Cavalieri L,Piraino A,Paleari D,Quarta E,Sonvico F,Melani AS,Buttini F

    更新日期:2020-07-01 00:00:00

  • Evaluation of material properties and compression characteristics of Assam Bora rice flours as a directly compressible vehicle in tablet formulation.

    abstract:AIM:The mechanical properties and compaction characteristics of different varieties of Assam Bora rice flours (ABRFs) were evaluated and compared with those of official Starch 1500®. METHODS:The material properties and compression characteristics of Assam Bora rice flours were studied by Heckel and Kawakita analysis. ...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章

    doi:10.1517/17425247.2013.736963

    authors: Ahmad MZ,Akhter S,Dhiman I,Sharma P,Verma R

    更新日期:2013-02-01 00:00:00

  • Innovative therapeutics: from molecules to medicines. 27 June-7 July 2004, Parma, Italy.

    abstract::The Socrates Intensive Programme offers annual courses focusing on the specific aspects of innovative therapeutics. The 2004 meeting was coordinated by the University of Parma and covered various subjects in the field of advanced drug delivery and pharmaceutical technology, including sessions on biopharmaceutics, phar...

    journal_title:Expert opinion on drug delivery

    pub_type:

    doi:10.1517/17425247.1.1.185

    authors: Jiskoot W,Santi P

    更新日期:2004-11-01 00:00:00

  • Improved dissolution behavior of lipophilic drugs by solid dispersions: the production process as starting point for formulation considerations.

    abstract:INTRODUCTION:Many new drug substances have low aqueous solubility which can cause poor bioavailability after oral administration. The application of solid dispersions is a useful method to increase the dissolution rate of these drugs and thereby improve their bioavailability. So far, several methods have been developed...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2011.598147

    authors: Srinarong P,de Waard H,Frijlink HW,Hinrichs WL

    更新日期:2011-09-01 00:00:00

  • Process optimization for the production of nanoparticles for drug delivery applications.

    abstract::Various techniques have been developed to prepare nanoparticles for the delivery of drugs. The implementation of these techniques for large-scale production is still in its infancy, as it requires defined steps which include excipient compatibility, process feasibility, formulation optimization, process optimization, ...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425240902735806

    authors: Saraf S

    更新日期:2009-02-01 00:00:00

  • High-density lipoproteins for the systemic delivery of short interfering RNA.

    abstract:INTRODUCTION:RNA interference (RNAi) is a powerful mechanism for gene silencing with the potential to greatly impact the development of new therapies for many human diseases. Short interfering RNAs (siRNAs) may be the ideal molecules for therapeutic RNAi. However, therapeutic siRNAs face significant challenges that mus...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2014.866089

    authors: McMahon KM,Thaxton CS

    更新日期:2014-02-01 00:00:00

  • Mitochondria and neurodegenerative diseases: the promising role of nanotechnology in targeted drug delivery.

    abstract:INTRODUCTION:Neurodegenerative diseases (NDs) represent a group of different clinical entities that, despite the specific primary etiologies, share a common signature in terms of a general mitochondrial dysfunction with consequent oxidative stress accumulation. As these two events occur early during neurodegenerative p...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2016.1218461

    authors: Pezzini I,Mattoli V,Ciofani G

    更新日期:2017-04-01 00:00:00

  • Overcoming the barriers in micellar drug delivery: loading efficiency, in vivo stability, and micelle-cell interaction.

    abstract:IMPORTANCE OF THE FIELD:Spontaneously constructed from block copolymers in aqueous media, the polymer micelle has been extensively studied as a potential carrier of poorly water-soluble drugs, but cellular uptake pathways and stability of micelles in blood have not yet been clearly understood. An in-depth insight into ...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425240903380446

    authors: Kim S,Shi Y,Kim JY,Park K,Cheng JX

    更新日期:2010-01-01 00:00:00

  • Nanostructured hyaluronic acid-based materials for active delivery to cancer.

    abstract:IMPORTANCE OF THE FIELD:Active targeting of bioactive molecules by physicochemical association with hyaluronic acid (HA) is an attractive approach in current nanomedicine because HA is biocompatible, non-toxic and non-inflammatory. AREAS COVERED IN THIS REVIEW:This review focuses on synthesis, physicochemical characte...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425241003730399

    authors: Ossipov DA

    更新日期:2010-06-01 00:00:00

  • Drug delivery strategies for therapy of visceral leishmaniasis.

    abstract:IMPORTANCE OF THE FIELD:Visceral leishmaniasis (VL) is the most overwhelming type of leishmaniasis associated with the poverty of developing countries and usually mortal if untreated. Most of the conventionally used dosage forms offer us the shortcomings of toxic side effects and emergence of drug resistance. Several e...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425240903548232

    authors: Gupta S,Pal A,Vyas SP

    更新日期:2010-03-01 00:00:00

  • Cutaneous immunization: an evolving paradigm in influenza vaccines.

    abstract:INTRODUCTION:Most vaccines are administered by intramuscular injection using a hypodermic needle and syringe. Some limitations of this procedure include reluctance to be immunized because of fear of needlesticks, and concerns associated with the safe disposal of needles after their use. Skin delivery is an alternate ro...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2014.885947

    authors: Gill HS,Kang SM,Quan FS,Compans RW

    更新日期:2014-04-01 00:00:00

  • Current status of non-viral gene therapy for CNS disorders.

    abstract:INTRODUCTION:Viral and non-viral vectors have been used as methods of delivery in gene therapy for many CNS diseases. Currently, viral vectors such as adeno-associated viruses (AAV), retroviruses, lentiviruses, adenoviruses and herpes simplex viruses (HHV) are being used as successful vectors in gene therapy at clinica...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2016.1188802

    authors: Jayant RD,Sosa D,Kaushik A,Atluri V,Vashist A,Tomitaka A,Nair M

    更新日期:2016-10-01 00:00:00

  • Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapies.

    abstract::Cancer is the second leading cause of death in the US. Currently, protocols for cancer treatment include surgery to remove diseased and suspect tissues, focused radiation, systemic chemotherapy, immunotherapy and their combinations. With conventional chemotherapy, it is almost impossible to deliver anticancer drugs sp...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425240903085128

    authors: Xie Y,Bagby TR,Cohen MS,Forrest ML

    更新日期:2009-08-01 00:00:00

  • Ultrasonic nebulization platforms for pulmonary drug delivery.

    abstract:IMPORTANCE OF THE FIELD:Since the 1950s, ultrasonic nebulizers have played an important role in pulmonary drug delivery. As the process in which aerosol droplets are generated is independent and does not require breath-actuation, ultrasonic nebulizers, in principle, offer the potential for instantaneously fine-tuning t...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2010.485608

    authors: Yeo LY,Friend JR,McIntosh MP,Meeusen EN,Morton DA

    更新日期:2010-06-01 00:00:00

  • Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery.

    abstract:INTRODUCTION:Nanocarrier-based delivery systems offer multiple benefits to overcome limitations of the traditional drug dosage forms, such as protection of the drug, enhanced bioavailability, targeted delivery to disease site, etc. Nanocarriers have exhibited tremendous successes in targeted delivery of therapeutics to...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章

    doi:10.1080/17425247.2021.1828339

    authors: Majumder J,Minko T

    更新日期:2020-10-08 00:00:00

  • The latest advances of cisplatin liposomal formulations: essentials for preparation and analysis.

    abstract::Introduction: Cisplatin has been indicated for several malignancies all over the world for many years. Increasing patient tolerance for high dose of chemotherapeutics and reducing side effects has been granted by drug encapsulated liposomal systems. There have been much efforts for improving cisplatin delivery to the ...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2020.1737672

    authors: Zahednezhad F,Zakeri-Milani P,Shahbazi Mojarrad J,Valizadeh H

    更新日期:2020-04-01 00:00:00

  • Systemic delivery of therapeutics to neuronal tissues: a barrier modulation approach.

    abstract:IMPORTANCE OF THE FIELD:Efficient systemic delivery of low-molecular-mass therapeutics to neuronal tissue remains a central issue not only to drug development but also to the chronic treatment of a range of neurodegenerative disorders. AREAS COVERED IN THIS REVIEW:This review discusses the potential of using RNA inter...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2010.490554

    authors: Campbell M,Ozaki E,Humphries P

    更新日期:2010-07-01 00:00:00

  • Focused ultrasound for blood-brain disruption and delivery of therapeutic molecules into the brain.

    abstract::Noninvasive, transient and local image-guided blood-brain barrier disruption can be accomplished using focused ultrasound exposure with intravascular injection of preformed microbubbles. MRI-guided blood-brain barrier disruption has been demonstrated and has been shown to heal in within a few hours after exposure. The...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.4.1.27

    authors: Hynynen K

    更新日期:2007-01-01 00:00:00

  • Drug delivery into the brain using poly(lactide-co-glycolide) microspheres.

    abstract::Among the strategies developed for drug delivery into the CNS, locally controlled drug release by the way of an implantable polymeric device has been developed in recent years. The first polymeric devices developed were macroscopic implants needing open surgery for implantation. Over the last few years, poly(lactide-c...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2.2.363

    authors: Menei P,Montero-Menei C,Venier MC,Benoit JP

    更新日期:2005-03-01 00:00:00

  • Challenges in the pharmaceutical development of lipid-based short interfering ribonucleic acid therapeutics.

    abstract:INTRODUCTION:Harnessing RNA interference as a therapeutic approach has the potential to significantly expand the druggable target space, offering new hope for treatment of diseases that cannot be addressed with existing classes of drugs. A number of siRNA therapeutics have already progressed into preclinical and clinic...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2012.642363

    authors: Gindy ME,Leone AM,Cunningham JJ

    更新日期:2012-02-01 00:00:00

  • Advances in ocular drug delivery: emphasis on the posterior segment.

    abstract:INTRODUCTION:Recent advances in pharmacological therapies to treat ocular diseases such as glaucoma, age-related macular degeneration, diabetic macular edema and retinal vascular occlusions have greatly improved the prognosis for these diseases. Due to these advances in pharmacological therapy, there is a great deal of...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2014.935338

    authors: Kang-Mieler JJ,Osswald CR,Mieler WF

    更新日期:2014-10-01 00:00:00

  • Transdermal immunization: biological framework and translational perspectives.

    abstract:INTRODUCTION:The renaissance in drug delivery research during the past decade led to several new approaches toward vaccine development. Transdermal immunization (TI) is a promising modality with both practical and immunological merits. Compared with conventional routes of administration, this needle-free delivery appro...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2013.746660

    authors: Mishra DK,Dhote V,Mishra PK

    更新日期:2013-02-01 00:00:00

  • Nanocarrier-based antioxidant therapy: promise or delusion?

    abstract:INTRODUCTION:Oxidative stress has generally been recognized as an important factor in the pathogenesis of human diseases, making antioxidant therapy a plausible strategy to either prevent or treat human disorders. Yet so far, numerous antioxidant-based clinical trials aimed at developing clinically approved protocols h...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2015.1063611

    authors: Weissig V,Guzman-Villanueva D

    更新日期:2015-01-01 00:00:00

  • An update on the contribution of hot-melt extrusion technology to novel drug delivery in the twenty-first century: part I.

    abstract:INTRODUCTION:Currently, hot melt extrusion (HME) is a promising technology in the pharmaceutical industry, as evidenced by its application to manufacture various FDA-approved commercial products in the market. HME is extensively researched for enhancing the solubility and bioavailability of poor water-soluble drugs, ta...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2019.1609448

    authors: Kallakunta VR,Sarabu S,Bandari S,Tiwari R,Patil H,Repka MA

    更新日期:2019-05-01 00:00:00

  • Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier.

    abstract::Introduction: Current therapies of neurodegenerative or neurometabolic diseases are, to a large extent, hampered by the inability of drugs to cross the blood-brain barrier (BBB). This very tight barrier severely restricts the entrance of molecules from the blood into the brain, especially macromolecular substances (i....

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2020.1698544

    authors: Tosi G,Duskey JT,Kreuter J

    更新日期:2020-01-01 00:00:00